Colorado voters decriminalize psychedelic mushrooms

By THOMAS PEIPERT, Associated Press
Posted:
Updated:

DENVER (AP) — Colorado voters have passed a ballot initiative to decriminalize psychedelic mushrooms for people 21 and older and to create state-regulated “healing centers” where participants can experience the drug under supervision.

Colorado becomes the second state, after Oregon, to vote to establish a regulated system for substances like psilocybin and psilocin, the hallucinogens found in some mushrooms. The initiative, which would take effect in 2024, also will allow an advisory board to add other plant-based psychedelic drugs to the program in 2026.

Supporters argued that the state’s current approach to mental health has failed and that naturally occurring psychedelics, which have been used for hundreds of years, can treat depression, PTSD, anxiety, addiction and other conditions. They also said jailing people for the non-violent offense of using naturally occurring substances costs taxpayers money.

Natural Medicine Colorado, the group that promoted the measure, called its passage “a truly historic moment.”

“Colorado voters saw the benefit of regulated access to natural medicines, including psilocybin, so people with PTSD, terminal illness, depression, anxiety and other mental health issues can heal,” the group said in a prepared statement.

<p>A rabbi measures out a precise amount of psilocybin mushrooms during a ceremony on Nov. 6, 2021, in Denver. The Colorado city partially decriminalized psychedelic mushrooms by requiring law enforcement officers to treat them as their lowest priority.</p>

Andy Cross/The Denver Post via AP

A rabbi measures out a precise amount of psilocybin mushrooms during a ceremony on Nov. 6, 2021, in Denver. The Colorado city partially decriminalized psychedelic mushrooms by requiring law enforcement officers to treat them as their lowest priority.

Critics warned that the Food and Drug Administration has not approved the substances as medicine. They also argued that allowing “healing centers” to operate, and allowing private personal use of the drugs, would jeopardize public safety and send the wrong message to kids and adults alike that the substances are healthy.

“This opens a very large national conversation about the role of the FDA in determining medicines in this country,” said Luke Niforatos, the head of the opposition ballot committee, Protect Colorado’s Kids. “Because now, for the second time in a row, we’ve had states put medicine to a ballot vote and circumvent science and the FDA.”

Niforatos said his group is calling on the FDA, the Drug Enforcement Administration and the U.S. Attorney for Colorado to step in because the drugs are still federally illegal.

“Are we going to dispense with the FDA — the only institution in charge of protecting patient health and safety — and just say that we’re OK with statewide, nationwide experiments on whatever startup comes up with for a drug?” he asked.

The ballot initiative’s passage comes a decade after Colorado voted to legalize recreational marijuana, after initially allowing its use for medical reasons, which led to a multibillion-dollar industry with hundreds of dispensaries popping up across the state.

Critics of the latest ballot initiative say the same deep-pocketed players who have pushed for legalizing recreational marijuana in various states are using a similar playbook to create a commercial market, and eventually recreational dispensaries, for dangerous substances.

Voters in this week’s midterm elections approved recreational marijuana in Maryland and Missouri but rejected it in two other states, signaling support gradually growing for legalization even in conservative parts of the country.

The results mean that 21 states have approved marijuana’s recreational use.

Under Colorado’s measure, the psychedelics that would be decriminalized are listed as schedule 1 controlled substances under state and federal law and are defined as drugs with no currently accepted medical use with a high potential for abuse.

Even so, the FDA has designated psilocybin a “breakthrough therapy” to treat major depressive disorder. The designation can expedite research, development and review of a drug if it might offer substantial improvements over existing treatments.

Colorado’s ballot initiative would allow those 21 and older to grow, possess and share the psychedelic substances but not sell them for personal use. It also would allow people who have been convicted of offenses involving the substances to have their criminal records sealed.

Those who want to use mushrooms would not need approval from a doctor. In addition to being able to grow and use their own mushrooms, those who want to try the therapy could do so through the newly formed “healing centers,” which would be allowed to supply clients with mushrooms but not sell them. Instead, clients would pay for the services of the “facilitator” at the center.

Proponents have stressed that the measure does not allow dispensaries like those selling recreational and medical marijuana.

In 2020, Oregon became the first state in the nation to legalize the therapeutic, supervised use of psilocybin after 56% of voters approved Ballot Measure 109. But unlike the Colorado measure, Oregon allows counties to opt out of the program if their constituents vote to do so.

Oregon’s initiative is expected to take effect at the beginning of next year.

Washington, D.C., and Denver have partially decriminalized psychedelic mushrooms by requiring law enforcement officers to treat them as their lowest priority.

Submit a tip or story idea // Report a typo or error

Current Top Stories